EPCAM and nonpapillary renal cell carcinoma: Using flow cytometry, we identified expression of renal‐specific markers on ccRCC CTCs and utilized a highly sensitive CTC microfluidic platform to confirm the presence of different subsets of CTCs that express different combinations of CK, EpCAM, CAIX, and/or CAXII.